What is EAG (Estimated Average Glucose)?

EAG (Estimated Average Glucose) is a calculation that converts your HbA1c percentage into an average blood sugar reading in mg/dL or mmol/L. This makes it easier to understand your overall glucose control by showing what your average blood sugar has been over the past 2-3 months.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding EAG: Your Average Blood Sugar Snapshot

If you've ever had your HbA1c tested, you might have noticed another number on your lab report: EAG, or Estimated Average Glucose. While HbA1c is expressed as a percentage, EAG translates that percentage into the same units used by glucose meters (mg/dL or mmol/L), making it more intuitive for many people to understand their blood sugar control.

EAG represents your average blood glucose level over the past 2-3 months, providing a broader picture of your metabolic health than a single glucose reading. This metric has become increasingly important not just for people with diabetes, but for anyone interested in optimizing their metabolic health and preventing chronic disease.

The Science Behind EAG Calculation

EAG is calculated directly from your HbA1c value using a formula developed through extensive research. The A1C-Derived Average Glucose (ADAG) study, which included over 500 participants with and without diabetes, established the mathematical relationship between HbA1c and average glucose levels.

Glucose Measurement Types and Their Uses

Measurement TypeWhat It ShowsNormal RangeBest Use Case
EAGEAG (Estimated Average Glucose)2-3 month average glucose< 114 mg/dLLong-term glucose control assessment
Fasting GlucoseFasting GlucoseBaseline glucose after 8-12 hour fast70-99 mg/dLDetecting early insulin resistance
Post-MealPost-Meal GlucoseGlucose response to food< 140 mg/dL at 2 hoursOptimizing diet and meal timing
RandomRandom GlucoseGlucose at any time< 140 mg/dLSpot-checking for symptoms

Each glucose measurement provides unique insights into your metabolic health and should be used together for comprehensive monitoring.

The formula for calculating EAG is: EAG (mg/dL) = 28.7 × HbA1c - 46.7. For those using mmol/L, the formula is: EAG (mmol/L) = 1.59 × HbA1c - 2.59. This calculation provides a reliable estimate of your average glucose levels based on the percentage of glycated hemoglobin in your blood.

Why HbA1c Translates to Average Glucose

Hemoglobin A1c forms when glucose in your bloodstream attaches to hemoglobin proteins in red blood cells through a process called glycation. Since red blood cells live for about 120 days, HbA1c reflects your average blood sugar exposure over approximately 2-3 months. The higher your average blood glucose, the more glycation occurs, resulting in a higher HbA1c percentage.

EAG vs. Other Glucose Measurements

Understanding how EAG differs from other glucose measurements can help you better interpret your metabolic health data. While fasting glucose gives you a snapshot of your blood sugar after not eating for 8-12 hours, and post-meal glucose shows how your body responds to food, EAG provides the big picture of your overall glucose control.

Each measurement serves a unique purpose in understanding your metabolic health. Fasting glucose can identify early insulin resistance, post-meal readings help optimize your diet, and EAG shows whether your overall approach is working. Regular monitoring of your metabolic biomarkers, including HbA1c and calculated EAG, provides comprehensive insights into your health status.

Limitations of EAG

While EAG is a valuable metric, it has some limitations. It represents an average, which means it can't show glucose variability or identify patterns of highs and lows. Two people with the same EAG might have very different glucose patterns - one with stable levels and another with significant swings. Additionally, certain conditions affecting red blood cell turnover, such as anemia or recent blood loss, can make EAG less accurate.

Interpreting Your EAG Results

For people without diabetes, an EAG below 114 mg/dL (corresponding to an HbA1c below 5.7%) is considered normal. An EAG between 114-140 mg/dL indicates prediabetes, while an EAG above 140 mg/dL suggests diabetes. However, optimal metabolic health often means aiming for even lower levels, with many experts recommending an EAG below 100 mg/dL for best long-term health outcomes.

It's important to note that EAG targets may vary based on individual factors such as age, pregnancy, and other health conditions. Working with healthcare providers to establish personalized goals based on your complete health picture is essential for optimal management.

EAG Goals for Different Populations

  • Healthy adults: EAG < 100 mg/dL (HbA1c < 5.0%) for optimal health
  • Prediabetes management: EAG < 114 mg/dL (HbA1c < 5.7%)
  • Type 2 diabetes: EAG < 154 mg/dL (HbA1c < 7.0%) for most adults
  • Pregnancy: EAG < 120 mg/dL (HbA1c < 6.0%) when possible
  • Older adults: Individualized based on health status and life expectancy

Clinical Applications of EAG

Healthcare providers use EAG to help patients better understand their diabetes management and make more informed decisions about treatment. Since patients often check their blood glucose at home using the same units as EAG, this measurement creates a common language between daily monitoring and long-term control.

EAG is particularly useful for adjusting medication dosages, evaluating the effectiveness of lifestyle interventions, and setting realistic goals. For example, if your EAG is 180 mg/dL but your home glucose readings average 150 mg/dL, this discrepancy might indicate that you're missing high readings at other times of day.

Factors That Influence EAG Accuracy

Several conditions can affect the accuracy of EAG calculations by altering red blood cell lifespan or hemoglobin glycation rates. Understanding these factors helps ensure proper interpretation of your results.

Conditions That May Affect EAG

  • Anemia or iron deficiency: Can falsely elevate or lower readings
  • Recent blood transfusion: Introduces red blood cells with different glycation
  • Hemoglobin variants: Certain genetic variants affect glycation rates
  • Kidney disease: Affects red blood cell production and lifespan
  • Pregnancy: Increased red blood cell turnover can lower HbA1c/EAG
  • Certain medications: Some drugs affect red blood cell lifespan

If you have any of these conditions, discuss with your healthcare provider whether EAG is the best metric for monitoring your glucose control, or if additional testing methods would provide more accurate information.

Using EAG for Health Optimization

Even if you don't have diabetes, tracking your EAG can provide valuable insights into your metabolic health. Research shows that keeping EAG in the optimal range reduces risk of cardiovascular disease, cognitive decline, and other chronic conditions. Many people use EAG as a key metric for longevity and healthspan optimization.

To improve your EAG, focus on consistent lifestyle habits rather than dramatic short-term changes. Since EAG reflects a 2-3 month average, sustainable improvements in diet, exercise, sleep, and stress management will have the most significant impact. Regular testing helps you track progress and adjust your approach as needed.

Strategies to Lower Your EAG

  • Reduce refined carbohydrate intake and focus on whole foods
  • Incorporate regular physical activity, especially after meals
  • Prioritize 7-9 hours of quality sleep nightly
  • Manage stress through meditation, yoga, or other relaxation techniques
  • Consider continuous glucose monitoring to identify problem foods
  • Stay hydrated and limit alcohol consumption
  • Work with healthcare providers to optimize any medications

The Future of Glucose Monitoring

As technology advances, we're seeing new ways to monitor and interpret glucose data. Continuous glucose monitors (CGMs) provide real-time data that complements EAG by showing glucose patterns and variability. Some researchers are exploring metrics like time in range (TIR) and glucose management indicator (GMI) as additional tools for comprehensive metabolic assessment.

The integration of EAG with other biomarkers and wearable data promises even more personalized insights into metabolic health. As we better understand the relationships between average glucose, glucose variability, and long-term health outcomes, EAG will likely remain an important but not exclusive metric for health optimization.

References

  1. Nathan, D. M., Kuenen, J., Borg, R., Zheng, H., Schoenfeld, D., & Heine, R. J. (2008). Translating the A1C assay into estimated average glucose values. Diabetes Care, 31(8), 1473-1478.[Link][PubMed][DOI]
  2. American Diabetes Association. (2023). Standards of Medical Care in Diabetes-2023. Diabetes Care, 46(Supplement 1), S1-S267.[Link][DOI]
  3. Bergenstal, R. M., Beck, R. W., Close, K. L., Grunberger, G., Sacks, D. B., Kowalski, A., ... & Cefalu, W. T. (2018). Glucose Management Indicator (GMI): A new term for estimating A1C from continuous glucose monitoring. Diabetes Care, 41(11), 2275-2280.[Link][PubMed][DOI]
  4. Selvin, E., Steffes, M. W., Zhu, H., Matsushita, K., Wagenknecht, L., Pankow, J., ... & Brancati, F. L. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine, 362(9), 800-811.[Link][PubMed][DOI]
  5. Beck, R. W., Connor, C. G., Mullen, D. M., Wesley, D. M., & Bergenstal, R. M. (2017). The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading. Diabetes Care, 40(8), 994-999.[Link][PubMed][DOI]
  6. Radin, M. S. (2014). Pitfalls in hemoglobin A1c measurement: when results may be misleading. Journal of General Internal Medicine, 29(2), 388-394.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my EAG at home?

You can test your EAG at home with SiPhox Health's Heart & Metabolic Program, which includes HbA1c testing that automatically calculates your EAG. This CLIA-certified program provides lab-quality results from the comfort of your home, with personalized insights to help optimize your metabolic health.

What's the difference between EAG and my daily glucose readings?

Daily glucose readings show your blood sugar at specific moments, while EAG represents your average glucose over the past 2-3 months. Your daily readings might vary from 70-180 mg/dL throughout the day, but your EAG shows the overall average, giving you a better picture of your long-term glucose control.

How often should I check my EAG?

For most people, checking EAG every 3-6 months is sufficient to track metabolic health trends. If you're actively working to improve your glucose control or have prediabetes, testing every 3 months allows you to see the impact of lifestyle changes. Those with stable results might test every 6 months.

Can EAG be normal even if I have glucose spikes?

Yes, EAG can appear normal even with significant glucose spikes because it's an average. If you have high spikes followed by low dips, they might average out to a normal EAG. This is why combining EAG testing with other tools like continuous glucose monitoring provides a more complete picture of your metabolic health.

What's a good EAG target for optimal health?

While an EAG below 114 mg/dL is considered normal, many longevity experts recommend aiming for an EAG below 100 mg/dL (corresponding to an HbA1c below 5.0%) for optimal health. This lower target is associated with reduced risk of chronic diseases and better long-term health outcomes.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details